As of 2025-03-16, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -4.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is -36.71 mil USD. DTIL's TTM EBITDA according to its financial statements is 9.04 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 12.2x | 10.2x |
| Forward P/E multiples | 10.8x - 21.6x | 16.2x |
| Fair Price | 19.09 - 34.45 | 24.82 |
| Upside | 278.8% - 583.5% | 392.5% |
| Date | EV/EBITDA |
| 2025-03-11 | -4.09 |
| 2025-03-10 | -4.01 |
| 2025-03-07 | -3.94 |
| 2025-03-06 | -3.96 |
| 2025-03-05 | -3.88 |
| 2025-03-04 | -4.02 |
| 2025-03-03 | -4.09 |
| 2025-02-28 | -3.75 |
| 2025-02-27 | -3.67 |
| 2025-02-26 | -3.65 |
| 2025-02-25 | -3.68 |
| 2025-02-24 | -3.54 |
| 2025-02-21 | -3.28 |
| 2025-02-20 | -3.32 |
| 2025-02-19 | -3.53 |
| 2025-02-18 | -3.96 |
| 2025-02-14 | -3.86 |
| 2025-02-13 | -4.04 |
| 2025-02-12 | -4.03 |
| 2025-02-11 | -4.19 |
| 2025-02-10 | -4.28 |
| 2025-02-07 | -4.36 |
| 2025-02-06 | -4.20 |
| 2025-02-05 | -4.15 |
| 2025-02-04 | -4.09 |
| 2025-02-03 | -4.38 |
| 2025-01-31 | -4.09 |
| 2025-01-30 | -3.91 |
| 2025-01-29 | -4.17 |
| 2025-01-28 | -4.06 |
| 2025-01-27 | -4.07 |
| 2025-01-24 | -4.02 |
| 2025-01-23 | -4.09 |
| 2025-01-22 | -4.12 |
| 2025-01-21 | -4.48 |
| 2025-01-17 | -4.13 |
| 2025-01-16 | -4.34 |
| 2025-01-15 | -3.87 |
| 2025-01-14 | -3.76 |
| 2025-01-13 | -3.45 |
| 2025-01-10 | -3.48 |
| 2025-01-08 | -4.53 |
| 2025-01-07 | -4.28 |
| 2025-01-06 | -4.36 |
| 2025-01-03 | -4.31 |
| 2025-01-02 | -4.36 |
| 2024-12-31 | -5.13 |
| 2024-12-30 | -4.74 |
| 2024-12-27 | -4.40 |
| 2024-12-26 | -4.33 |